Literature DB >> 25568566

Improvement of ejection fraction after coronary artery bypass grafting surgery in patients with impaired left ventricular function.

Ilirijana Haxhibeqiri-Karabdic1, Aida Hasanovic2, Emir Kabil3, Slavenka Straus1.   

Abstract

OBJECTIVES: The present study evaluates our experience with aorto-coronary bypass grafting in patients with severe dysfunction of left ventricle (LV) and low ejection fraction-EF(<35%). Revascularization of myocardium in this settings remains contraversial because of concerns over morbidity, mortality and quality of life. MATERIAL AND METHODES: Forty patients with severe coronary artery disease and dysfunction of LV (low ejection fraction <35%) underwent coronary artery bypass grafting in period of 3 years. Preoperative diagnostic of 40 patients was consisted of anamnesis, clinical exam, non-invasive methods EHO, MR and invasive diagnostic methods-cateterization. The major indication for surgery was severe anginal pain, heart failure symptoms and low ejection fraction. Internal mammary artery was used in all operated patients.
RESULTS: Average age of patients who have been operated was 59,8. In the present study, 81,3% were male and 18,8% female. We found one-vessel disease present in 2,5% (1/40) of patients, two -vessel disease in 40% (16/40), three-vessel disease in 42,5% (17/40) and four -vessel disease in 15% (6/40) of patients. One bypass grafting we implanted in 2,5% patients, two bypasses in 42,5%, three bypasses in 45 5%, and four bypasses in 10% of patients. Left ventricular ejection fraction assessed preoperativly was 18%-27% and postoperatively was improved to 31, 08% in period of 30 days.
CONCLUSION: In patients with left ventricular dysfunction, coronary artery bypass grafting can be performed safely with improvement in quality of life and in left ventricular ejection fraction.

Entities:  

Keywords:  coronary artery bypass-grafting; disfunction of LV; low ejection fraction

Mesh:

Year:  2014        PMID: 25568566      PMCID: PMC4269543          DOI: 10.5455/medarh.2014.68.332-334

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


1. INTRODUCTION

Traditionally impaired ventricular function has been a risk factor for mortality associated with coronary artery bypass grafting (1). Left ventricular function is important predictor of hospital mortality following coronary artery bypass grafting. Despite improvement in surgical tech­nique, myocardial protection and postoperative care, sur­gical risk remains high (2, 3, 4). Many studies show that patients have better quality of life and ejection fraction after coronary surgery than with continuous medical the­rapy (5, 6, 7, 8). Patients with coronary artery disease and poor left ventricular function have a poor outlook despite maximum medical therapy with a two year survival rate of only 20-30% (9). Numerous controlled trials of coro­nary artery bypass grafting in patients with depressed left ventricular ejection fraction, have shown that these are the patients that benefit most from revascularization, especially if symptoms of angina or ischemia are present (10). This benefit is not only for symptoms, but in this se­lected patient group also on longevity. It is important to determine first if any condition exist that may preclude intervention or that could raise the risk of revasculariza­tion above any potential benefit (11). This study evaluates short-term results after aortocoronary bypass grafting in patients with ejection fraction lower than 35%.

2. MATERIALS AND METHODS

During the years 2010 - 2013, 40 patients whose preo­perative ejection fraction EF was less than or equal to 35% (18%-27%) underwent aortocoronary bypass grafting. Preoperative and postoperative estimate of ejection frac­tion of all patients was performed. Research is performed based by medical evidence and observation of patients in intensive care of Heart Center of Clinical Center Univer­sity of Sarajevo. Transthoracal or transesophagal ehocardio Figurey was applied in all of 40 patients. Diagnosis of w ischemic disease was set by ultrasound overview. Most of the patients (30) were refered in hospital with done cathe­terization, and 10 of them are admitted as urgent cases and catheterization was done in admission. Heart scinti-Figurey was performed in 27 patients, which was essen­tial to show myocardial viability. Operative technique of surgery revascularization included sternotomy, the use of a. thoracica interna, venous grafts and extracorporal circulation (ECC). Evaluation of patients was one month after aortocoronary bypass grafting. Statistical analysis of the results was performed using x2 test. For comparison of variables was used parametric test (Student's test). When the distribution of continuous variables was unsymmetrical, for showing average value and a measures of disper­sion were used median and interquantile range, and for their comparison nonparametric tests (Mann - Whitney test). For the statistical analysis of obtained data was used statistical package IBM statistics SPPS v 19.0.

3. RESULTS

Results of our research are presented on tables and Figureics. Mean age of patients who have been operated was 59,8+7,7. In the present study, 81,3% of our 40 pa­tients were male and 18,8% female. In our study we fo­und one-vessel disease present in 2,5% (1/40) of patients, two-vessel disease in 40% (16/40), three-vessel disease in 42,5% (17/40) and four-vessel disease in 15% (6/40) of patients (Figure 1). Preoperative clinical data included in this group of patients were: examined patients mostly be­longed to New York Heart Association-NYHA III 65% or (26/40), NYHAIII/IV were 17,5% or (7/40), and to NYHA IV belonged 10% or (4/40) (Table 1).
Figure 1

Number of vessel disease present in patients preoperatively

Table 1

NYHA classification

Number of vessel disease present in patients preoperatively NYHA classification The number of implanted bypasses in operated pati­ents was: one bypass in 2,5% (1/40), 2 bypasses in 42,5% (17/40), 3 bypasses in 45% (18/40), and 4 bypasses in 10% (4/40) of patients (Figure 2).
Figure 2

Coronary arteries bypass grafting in operated patients

Coronary arteries bypass grafting in operated patients Anginal pain was present in 22 patients preoperatively. Mostly of the patients had before myocardial infarction and the pain was mostly present at rest and during mini-malphysicalactivity. After ao rtocortonary bypasses in a 55% patients (22/40) anginal pain dissapeared (Figure 3).
Figure 3

Preoperative and postoperative angina pectoris

Preoperative and postoperative angina pectoris Heart failure symptoms were present preoperatively in 42,5% (17/40). In this group of we had patients with COBP (chronical pulmonary disease). After aortocoro­nary bypass grafting heart failure symptoms were present in only 5% (2/40). Ejection fraction preoparatively was in range from 18%- 27%, and average value was 25%. After the aortocoronary bypass grafting ejection fraction increased from 25,6±5,2 to 31,08±5,5 postoperatively. This was evaluated 30 days after operation (Figure 4).
Figure 4

Ejection fraction pre and postoperatively.

Ejection fraction pre and postoperatively.

4. DISCUSSION

Selection of patients with ischemic heart disease who will benefit from coronary revascularization often is pro­blematic. Some authors correctly note that coronary artery bypass grafting (CABG) carries increased risk in this patient group. Indeed, several authors have suggested that recruitable contractile reserve is an important determi­nant of improvement after CABG in ischemic heart di­sease patients who undergo surgery (primary for heart failure) (11, 12, 13). Patients without such reserve are less likely to benefit simptomatically from CABG whereas those with reser­ve are. Further, studies have shown that ischemic heart disease patient with a low left ventricle EF who under­go surgery primarily for angina are more likely to obtain symptomatic benefitthan are those who undergo surgery primarily for heart failure (14, 15, 16, 17). Mickleborough LL et al. (2000) reported no difference in long-time survival between patients who underwent surgery primarily for angina and patients who underwent surgery for heart failure (18). Although one can define a subset of ischemic cardiomyopathy patients who are likely to have an increase in left ventricle EF with CABG, this information often has not proven useful in predicting improvement in functional class. Moreover, improvement in mortality after revascularization of viable myocardium may have little to do with change in either ejection fraction or functional class. Instead, improvement may be result of other factors, such as electric stabilization or reduction of ischemic events (19, 20). Indeed, existing data from observational studies indicate no difference in survival after CABG between patients with left ventricle EF improvement and patients without, again suggesting that changes in contractile function may not be the most helpful surrogate endpoint (21). The most important findings of this study can be summarized as follows. First, the magnitude of improvement in left ventricle EF is directly related to the extent of dysfunctional but viable issue. Second, the presence and extent of viability is predictive of the improvement in heart failure symptoms after revascularization.

5. CONCLUSION

The present study shows a significant improvement in both angina and heart failure status, not only objectively but also large enough to be of clinical revelance. Patients with angina as the main symptom were significantly more likely to improve their left ventricular ejection fraction af­ter surgery. These findings are consistent with the concept that the preoperative angina predicts a good result, but its absence is not necessarily associated with a poor result. Ischemic dysfunction may be reversible or not, the de­gree of reversibility probably determining which patients will respond favourably to CABG. Potentially reversible dysfunction should be assessed when considering CABG for patients with poor left ventricular function (ischemic or hibernating myocardium).
  21 in total

1.  Coronary artery bypass grafting in patients with poor left ventricular function.

Authors:  Fatih Lslamoglu; Anil Ziya Apaydin; Hakan Posacioglu; Mustafa Ozbaran; Ahmet Hamulu; Suat Buket; Ali Telli; Isa Durmaz
Journal:  Jpn Heart J       Date:  2002-07

Review 2.  Timing of coronary artery bypass graft surgery following acute myocardial infarction: a critical literature review.

Authors:  Arthur W Crossman; Harry J D'Agostino; Stephen A Geraci
Journal:  Clin Cardiol       Date:  2002-09       Impact factor: 2.882

3.  Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction.

Authors:  Joseph J DeRose; Ioannis K Toumpoulis; Sandhya K Balaram; John P Ioannidis; Scott Belsley; Robert C Ashton; Daniel G Swistel; Constantine E Anagnostopoulos
Journal:  J Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 5.209

4.  Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina.

Authors:  S J Pocock; R A Henderson; T Clayton; G H Lyman; D A Chamberlain
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

5.  Predictors of the successful outcome of one-year survivors of coronary artery bypass surgery.

Authors:  C J Eales; T D Noakes; A V Stewart; P Becker
Journal:  Cardiovasc J S Afr       Date:  2005 Jan-Feb

6.  Results of revascularization in patients with severe left ventricular dysfunction.

Authors:  L L Mickleborough; S Carson; M Tamariz; J Ivanov
Journal:  J Thorac Cardiovasc Surg       Date:  2000-03       Impact factor: 5.209

7.  Emergency and elective coronary artery bypass grafting: comparisons of risk profiles, postoperative outcomes, and resource requirements.

Authors:  Tuula S Kurki; Matti Kataja; David L Reich
Journal:  J Cardiothorac Vasc Anesth       Date:  2003-10       Impact factor: 2.628

8.  Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery.

Authors:  Raimondo Ascione; Pradeep Narayan; Chris A Rogers; Kelvin H H Lim; Radek Capoun; Gianni D Angelini
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

9.  VA Study of Unstable Angina. 10-year results show duration of surgical advantage for patients with impaired ejection fraction.

Authors:  S M Scott; R H Deupree; G V Sharma; R J Luchi
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

Review 10.  In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

Authors:  Ajay M Shah; Douglas L Mann
Journal:  Lancet       Date:  2011-08-20       Impact factor: 79.321

View more
  4 in total

1.  Myocardial Function Prediction After Coronary Artery Bypass Grafting Using MRI Radiomic Features and Machine Learning Algorithms.

Authors:  Fatemeh Arian; Mehdi Amini; Shayan Mostafaei; Kiara Rezaei Kalantari; Atlas Haddadi Avval; Zahra Shahbazi; Kianosh Kasani; Ahmad Bitarafan Rajabi; Saikat Chatterjee; Mehrdad Oveisi; Isaac Shiri; Habib Zaidi
Journal:  J Digit Imaging       Date:  2022-08-22       Impact factor: 4.903

2.  10-year outcomes post coronary artery bypass grafting in Asian patients with ischemic cardiomyopathy: a comprehensive analysis of survival and cardiac performance.

Authors:  Simon C Y Chow; Randolph H L Wong; Peter S Y Yu; Jacky Y K Ho; Joyce W Y Chan; Micky W T Kwok; Song Wan; Takuya Fujikawa; Malcolm J Underwood
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

3.  Our Experiences in the Treatment of Anterior Chest Wall Infections (2015 - 2021).

Authors:  Bedrudin Banjanovic; Ilirijana Haxibeqiri Karabic; Slavenka Straus; Nermin Granov; Edin Kabil; Malik Jakirlic; Ilijaz Pilav; Muhamed Djedovic
Journal:  Mater Sociomed       Date:  2022-06

4.  Comparative Analysis of Web of Science and Pubmed Indexed Medical Journals Published in Former Yugoslav Countries.

Authors:  Izet Masic; Slobodan M Jankovic
Journal:  Med Arch       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.